Detalhe da pesquisa
1.
Durvalumab impacts progression-free survival while high-dose radiation >66 Gy improves local control without excess toxicity in unresectable NSCLC stage III: Real-world data from the Austrian radio-oncological lung cancer study association registry (ALLSTAR).
Radiother Oncol
; 196: 110294, 2024 Apr 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38653380
2.
Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DLCO Correlate with Radiation Dosimetry and Pneumonitis Rate.
Cancers (Basel)
; 15(7)2023 Mar 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37046627
3.
Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapy.
Radiother Oncol
; 185: 109728, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37301259
4.
Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity.
Cancers (Basel)
; 14(13)2022 Jun 30.
Artigo
Inglês
| MEDLINE | ID: mdl-35804997
5.
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC.
Cancers (Basel)
; 14(3)2022 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-35158841
6.
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3.
Breast Cancer
; 29(2): 274-286, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34865205
7.
Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III.
Diagnostics (Basel)
; 12(5)2022 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35626183
8.
Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis.
Curr Oncol
; 28(3): 1835-1846, 2021 05 13.
Artigo
Inglês
| MEDLINE | ID: mdl-34068043
9.
Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single-center retrospective analysis.
Thorac Cancer
; 12(8): 1162-1170, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33586228
10.
Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC: A systematic review.
Thorac Cancer
; 11(6): 1375-1385, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32323484
11.
Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast Cancer.
Genes (Basel)
; 11(12)2020 11 26.
Artigo
Inglês
| MEDLINE | ID: mdl-33255991
12.
Pulmonary function decreases moderately after accelerated high-dose irradiation for stage III non-small cell lung cancer.
Thorac Cancer
; 11(2): 369-378, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31855325
13.
Toxicity and cosmetic outcome after hypofractionated whole breast irradiation and boost-IOERT in early stage breast cancer (HIOB): First results of a prospective multicenter trial (NCT01343459).
Radiother Oncol
; 146: 136-142, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32151790